Apparent resistance in human endometrial carcinoma during combination treatment with tamoxifen and progestin may result from desensitization following downregulation of tumor progesterone receptor.

Source:http://linkedlifedata.com/resource/pubmed/id/1540937

Cancer Lett. 1992 Feb 29 62 2 107-14

Download in:

View as

General Info

PMID
1540937